A5046184528- Cardiac Valve Diseases and Treatments
- Vascular Procedures and Complications
- Coronary Interventions and Diagnostics
- Infective Endocarditis Diagnosis and Management
- Aortic Disease and Treatment Approaches
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Viral Infections and Immunology Research
- Acute Myocardial Infarction Research
- Central Venous Catheters and Hemodialysis
- Cardiac and Coronary Surgery Techniques
- Peripheral Artery Disease Management
- Cardiac Arrhythmias and Treatments
- Employment and Welfare Studies
- Cardiac Structural Anomalies and Repair
- Hydraulic and Pneumatic Systems
- Antiplatelet Therapy and Cardiovascular Diseases
- Hemodynamic Monitoring and Therapy
- Mechanical Circulatory Support Devices
- Heparin-Induced Thrombocytopenia and Thrombosis
- Transplantation: Methods and Outcomes
- Cardiac electrophysiology and arrhythmias
- Trauma Management and Diagnosis
- Pain Management and Treatment
- Aortic aneurysm repair treatments
Fondazione Poliambulanza Istituto Ospedaliero
2023-2024
Clinique Pasteur
2022-2024
University of Verona
2017-2022
Society of Interventional Radiology
2022
October 6 University
2022
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2022
IRCCS Policlinico San Donato
2021
Provincia Autonoma di Trento
2017
Massachusetts General Hospital
2016
Transcatheter aortic valve replacement (TAVR) in patients with bicuspid (BAV) stenosis is technically challenging and burdened by an increased risk of paravalvular regurgitation (PVR).
Background: Radial artery occlusion (RAO) is a thrombotic complication of transradial catheterization that can lead to permanent the radial artery. Sheath-vessel diameter ratio, postprocedure compression time, occlusive hemostasis, and insufficient anticoagulation are all predictors RAO. However, excessive longer time achieve complete hemostasis less patent rate. This study was designed assess relationship among residual at end percutaneous coronary procedure risk Methods: Eight hundred...
To compare incidence of forearm radial artery occlusion (RAO) and hemostasis characteristics between distal conventional transradial approach (DRA TRA, respectively).DRA has the potential advantage reducing RAO. DRA effectively reduces time-to-hemostasis, however its role on preserving flow in (PF) during consequent impact RAO remains speculative.Eight hundred thirty-seven patients with TRA were previously enrolled a prospective registry investigating relationship residual anticoagulation...
Abstract Introduction Bicuspid aortic valve (BAV) stenosis is a complex anatomical scenario for transcatheter implantation (TAVI). Favorable short‐term clinical outcomes have been reported with TAVI in this setting, but long‐term data are scarce. Methods We retrospectively included, single‐center registry, patients BAV who underwent before 2020. compared treated self‐expanding valves (SEV) versus balloon‐expandable (BEV). The primary endpoint was composite of all‐cause mortality, stroke and...
de Manna, Nunzio Davide; Bellamoli, Michele; Santoro, Francesco; Vinco, Giulia; Pilati, Mara; Ribichini, Flavio; Faggian, Giuseppe; Milano, Aldo Domenico Author Information
Redo transcatheter aortic valve replacement (TAVR) may pose the risk of coronary flow obstruction. We report 2 cases severe TAVR regurgitation due to different physiopathological mechanisms in which TAVR-in-TAVR could be at high for sinus sequestration. Both were successfully treated by in-series implantation a second heart valve, thus avoiding (Level Difficulty: Intermediate.)
Abstract Objectives To assess the independent predictors of patent and occlusive hemostasis (PH OH, respectively) during radial after coronary procedures. Background Radial artery occlusion (RAO) is a thrombotic complication transradial catheterization that can lead to permanent artery. Sheath‐vessel diameter ratio, postprocedure compression time, hemostasis, inadequate, excessive anticoagulation are all RAO. Methods As part previously published study investigating relationship between...
Restivo, Attilio; Bianchini, Emiliano; Bellamoli, Michele; Buono, Andrea; Bettari, Luca; Stanzione, Alessio; De Ornelas, Benjamin; Maffeo, Diego Author Information
Bellamoli, Michelea; Pellegrini, Paolob; de Manna, Nunzio Davidec; Genco, Brunod; Prati, Danielea; Carbonieri, Emanueleb; Faggian, Giuseppec; Ammirati, Enricoe; Frigerio, Mariae; Ribichini, Flavio Lucianoa Author Information
The transradial access (TRA) for cardiac catheterization and percutaneous coronary intervention (PCI) has been widely adopted in the last decades since its first description late forties. approach associated with favourable outcomes as compared transfemoral (TFA) several registries randomized clinical trials, mainly due to lower incidence of access-site bleedings, vascular complications improved patient comfort. This review aims summarize body evidence supporting use TRA, discuss...
The coronary sinus reducer: a validate option for "no-option" labeled patients.Clinical evidences and new perspectives Reductor del seno coronario: una opción de validación para pacientes etiquetados "no opción".
Introduction The coronavirus disease 2019 (COVID-19) pandemic, associated with the infection of severe acute respiratory syndrome 2 (SARS-CoV-2), started in late China before spreading all over world. Symptoms include fever, cough, loss taste and/or smell, dyspnea, and thromboembolic manifestations. It is a potentially lethal particularly patients clinical risk factors (elderly, immunocompromised, obese, hypertensive, others) responsible for >6 million deaths world at time writing.1 Massive...
Third generation drug-eluting stents (DES) potentially offer better technical performance and reduced neointimal proliferation than previous DES. The XLIMIT non-inferiority trial evaluated the of Xlimus (a novel sirolimus-eluting coronary stent system) in terms endothelialization tissue healing compared to bioresorbable polymer Synergy DES.A total 177 patients undergoing percutaneous intervention (PCI) were randomized a 2:1 ratio (2 Xlimus: 1 Synergy). primary endpoints, defined as in-stent...